Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Cognitive Impairment, Cognitive Decline, Radiotherapy Side Effect, Radiotherapy; Complications, Brain Tumor, Memory Impairment, Late Effect of Radiation

In brief

Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors. Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.

Key facts

Study ID
NCT06051240
Run by
Region Stockholm
People needed
84
Starts
2024-02-16
Expected to finish
2033-08-31
Last updated by the study team
2024-04-12

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.